白介素15(IL15)cDNA
cDNA of Interleukin 15 (IL15)
產(chǎn)品包裝(模擬)
產(chǎn)品包裝(模擬)
通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
用法
利用無菌水稀釋到10-100ng/ml.
儲存
避免反復(fù)凍融。2-8°C不超過一個月，-20°C不超過12個月。
贈品
相關(guān)產(chǎn)品
| 編號 | 適用物種：Sus scrofa; Porcine (Pig，豬) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPA061Po01 | 白介素15(IL15)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| APA061Po01 | 白介素15(IL15)活性蛋白 | Cell?culture;?Activity?Assays. |
| PAA061Po01 | 白介素15(IL15)多克隆抗體 | WB; IHC; ICC; IP. |
| CGA061Po01 | 白介素15(IL15)cDNA | PCR、蛋白表達(dá)等 |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| Endocrine | Expression of interleukin-15 and inflammatory cytokines in skeletal muscles of STZ-induced diabetic rats: effect of resistance exercise training[Pubmed: 24006180] |
| Endocrine | Time course of IL-15 expression after acute resistance exercise in trained rats: effect of diabetes and skeletal muscle phenotype[Pubmed:25522723] |
| Med Sci Moni | miR-15b is Downregulated in Myasthenia Gravis Patients and Directly Regulates the Expression of Interleukin-15 (IL-15) in Experimental Myasthenia Gravis Mice[PubMed: 26087886] |
| Exercise physiology | Effects of intrinsic aerobic capacity, aging and physical activity on interleukin-15 protein level in serum and skeletal muscle[Dspace: Handle] |
| Biotechnology Letters | Novel adjuvant for immunization against tuberculosis: DNA vaccine expressing Mycobacterium tuberculosis antigen 85A and interleukin-15 fusion product elicits strong immune responses in mice[s10529-017-2342-1] |
| Journal?of?Controlled?Release | Interleukin-15 and cisplatin co-encapsulated thermosensitive polypeptide hydrogels for combined immuno-chemotherapy.[pubmed:28408199] |